Tailoring Obesity Treatment Trial

NCT06619015 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped suspended by the danish medical agency

Conditions

Obesity
Appetite Regulation
PreDiabetes

Interventions

DRUG: Pramlintide Acetate 1 MG/ML
DRUG: Semaglutide Pen Injector
DRUG: Sodium Chloride 0.9% Inj

Sponsor

Esbjerg Hospital - University Hospital of Southern Denmark